Cholesterol Drug That Works Differently Than Widely Prescribed Statin Pills Approved By FDA

Esperion’s drug, called Nexletol, lowers low-density lipoprotein, colloquially known as "bad cholesterol," by 17% over the course of 12 weeks of treatment. “This is a nice alternative” to statins, but those medicines will still be the first choice, said Dr. Christie Ballantyne, Baylor College of Medicine's cardiology chief.

from Kaiser Health News https://ift.tt/32oWQLT